Valeant Pharmaceuticals Acquires Ambi Skin Care

Valeant Pharmaceuticals Acquires Ambi Skin Care

Contact Author
Close
Fill out my online form.

Skin care brand Ambi is transitioning from one parent company to another. Johnson & Johnson has sold the Ambi brand to Valeant Pharmaceuticals North America. Valeant is a multinational, 17 billion market cap pharmaceutical/OTC company based in Bridgewater, New Jersey. It also owns beauty brand Kinerase, AcneFree, CeraVe and more, in addition to multiple derm brands and other pharmaceutical product brands.